FDA Investigator Ronald R Ruff

Ronald R Ruff has conducted inspections on 85 sites in 1 countries as of 13 Jan 2005. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
85
Last Inspection Date:
13 Jan 2005
Investigator Role:
FDA Investigator
Redica ID:
100005667
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Ronald R Ruff:
Aaron L Dunbar, Aimee J Edwin, Alan M Roberts, Alfred P Pistorio, Anders W Evenson, April L Brown, April L Young, Boun M Xiong, Brian L Szcyubialka, Bruce Huang, Carl A Huffman, III, Carolyn A Warren, Charles R Bonapace, PhD, Charles R Cote, RIC, Chase Bourke, PhD, Corey K Reno, Demetria L Lueneburg, Denise L Burosh, Diane T Reindl, Dina A Tallman, Dr. Gopa Biswas, PhD, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dr. Zhou Chen (nmi), MD PhD, Elizabeth E Hart (ASCP), MT, Elizabeth P Mayer, Ellen C Weisensel, Eric S Myskowski, Eric T Huebler, Fannie M Harrell, Gajendiran Mahadevan, PhD, Grant M Ruis, Gregory R Brinsley, Gregory W Smith, Heather Akleimola Hulbert, Howard A Burmester, Hyojong Kwon, PhD, Jacob W Reynolds, James K Ireland, Jasjeet K Sekhon, Jeffry A Bernhardt, Jesse P Romenesko, Jessica L Barr, Joel D Hustedt, John A Kadavil, PhD, Jon C Polzine, Joseph D Gong, Justin A Boyd, Justin J Jafferis, Jyoti B Patel, PhD, Kailas Nagaraj, Kara A Scheibner, PhD, Karen M Labounty, Karla J Youngberg, Kellie L Thommes, RN, Kimberly Lewandowski Walker, Linda V Weyer, Lisa M Lopez, Lori B Wikstrom, M Edith Snyder, Mada A Tautges, Marie A Fadden, Martin K Yau, PhD, Maryann Ruff, Melanie C Voges, Melissa I Michurski, Melissa J Holz, Michael F Skelly, PhD, Michelle J Glembin, Mohammed H Adam, Mohsen Rajabi Abhari, FDA, Natalie E Starczowski, Nicholas J Dubrovin, Nicholas S Vasilakes, Nicole C Victoria, PhD, Patricia A Holmstrom, Patrick J Lynch, Peter T Erlandson, Rebecca L Caulfield, Richard Jay Tucker, RS, Richard M Willey, Richard W Koller, Sandra A Hughes, Sandra D Wilson, Sandra Sejdinovic, Sarah A Palmer, Scott B Laufenberg, Sharon K Thoma, PharmD, Sharon L Matson, Susan M Miller, Tanya L Keigley, Tara M Carolfi, Theresa C Klaman, Tyson J Eldridge Stedman, William E Keer, William Hallett, PhD, William P Fournier, Xiaohan Cai, PhD

Ronald R Ruff's Documents

Publish Date Document Type Title
January, 2000 FDA 483 Gemini Scientific - Form 483, 2000-01-20
May, 2002 FDA 483 Gidal, Barry E., Pharm.D., Clinical Investigator - Form 483, 2002-05-28
April, 2000 EIR Labcorp Early Development Laboratories, Inc. - EIR, 2000-04-05
September, 2000 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2000-09-01
January, 2004 EIR Covance Clinical Research Unit Irb - EIR, 2004-01-16
February, 2002 EIR Bretza, Joseph A. M.D., Clinical Investigator - EIR, 2002-02-04
July, 2001 EIR Mayo Clinic IRB - EIR, 2001-07-24
August, 2003 EIR PPD Development, L.P. - EIR, 2003-08-05
January, 2000 EIR Bittar, Neville, M.D./Gemini Scientific - EIR, 2000-01-20
April, 2000 FDA 483 Response Labcorp Early Development Laboratories, Inc. - Form 483R, 2000-06-01
April, 2000 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2000-04-05
November, 2000 FDA 483 Genzyme Corp. - Form 483, 2000-11-22
February, 2000 EIR Kealey Pharmacy and Homecare Service - EIR, 2000-02-16
July, 2003 FDA 483 Coating Place Inc - Form 483, 2003-07-14
February, 2000 FDA 483 Kealey Pharmacy and Homecare Service - Form 483, 2000-02-16
July, 2004 EIR PPD Development, L.P. - EIR, 2004-07-15
February, 2005 FDA 483 Response Labcorp Early Development Laboratories, Inc. - Form 483R, 2005-03-09
December, 2001 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2001-12-06
May, 2000 FDA 483 SPERIAN EYE & FACE PROTECTION, INC. - Form 483, 2000-05-25
August, 2001 EIR Scientific Protein Laboratories LLC - EIR, 2001-08-29
May, 2002 EIR Gidal, Barry E., Pharm.D., Clinical Investigator - EIR, 2002-05-28
February, 2005 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2005-02-10
April, 2001 EIR Labcorp Early Development Laboratories, Inc. - EIR, 2001-04-11
June, 2003 EIR Labcorp Early Development Laboratories, Inc. - EIR, 2003-06-13
April, 2001 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2001-04-11
August, 2001 EIR Backonja, Misha-Miroslav, M.D. , Clinical Investigator - EIR, 2001-08-15
July, 2001 FDA 483 Mayo Clinic Rochester - Form 483, 2001-07-24
October, 2003 FDA 483 Geneva Laboratories, Inc. - Form 483, 2003-10-31
April, 2001 FDA 483 Response Labcorp Early Development Laboratories, Inc. - Form 483R, 2001-05-17
February, 2002 FDA 483 Advanced Healthcare, S.C. - Form 483, 2002-02-04
December, 2001 EIR Labcorp Early Development Laboratories, Inc. - EIR, 2001-12-06
September, 2000 EIR Labcorp Early Development Laboratories, Inc. - EIR, 2000-09-01
December, 2001 FDA 483 Response Labcorp Early Development Laboratories, Inc. - Form 483R, 2001-12-20
March, 2004 FDA 483 Murtaugh, Thomas E., M.D., Clinical Investigator - Form 483, 2004-03-26
March, 2004 FDA 483 Bridson, William MD, Clinical Investigator - Form 483, 2004-03-26
February, 2005 EIR Labcorp Early Development Laboratories, Inc. - EIR, 2005-02-10

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more